As of 4:00pm ET
| +0.01 / +0.09%|
The 2 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 11.49, with a high estimate of 12.00 and a low estimate of 10.97. The median estimate represents a +8.15% increase from the last price of 10.62.
The current consensus among 2 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.